CTA Icon

Experience the new SureSeq Myeloid MRD Panel, for ultra-low variant detection enabling stronger characterization of your sample's AML status

An integrated approach to detection

For accurate detection of all types of genetic aberrations, various technologies are required. By combining information from multiple technologies, researchers can analyse complex samples and get the most complete overview of disease-driving mutations.

OGT offers an integrated portfolio of products providing clinical researchers with the most advanced tools available to study hematological disorders, including CytoCell® fluorescence in-situ hybridization (FISH) probes and myProbes® custom FISH probes, SureSeq™ next generation sequencing (NGS) panels and myPanel™ custom panels, and CytoSure® array products and custom arrays.

Our products are backed by deep technical expertise and dedicated customer support.

Search our range of hematology products

All hematology products

View

Acute myeloid leukemia (AML)

View

Chronic lymphocytic leukaemia (CLL)

View

Myelodysplastic syndromes (MDS)

View

Myeloid

View

Myeloproliferative neoplasms (MPN)

View

Featured hematology products

NGS panels

Graph showing example coverage profile of target regions in the SureSeq Myeloid MRD Panel, including NPM1 exon 11.

SureSeq Myeloid MRD Panel

The highly targeted SureSeq™ Myeloid MRD Panel enables the detection of 13 key AML MRD-associated biomarkers to provide a more comprehensive picture of the current AML status of your samples. Key targets include very large, ultra-low frequency FLT3-ITDs (even up to 300 bp) that are traditionally challenging to detect. The streamlined, guideline-driven panel content expands on OGT customer’s MRD detection capabilities to deliver a better understanding of the current AML status, and ensures genomic insights are not missed.

View Product
NGS software data showing detection of a SF3B1 exon 15 hotspot variant Lys700Glu and a TP53 exon 4 frameshift deletion.

SureSeq CLL + CNV V3 Panel

Improving upon existing SureSeq™ technology, this latest SureSeq NGS panel unlocks more efficient and expansive genetic profiling for CLL samples. The figure (above) illustrates the panel's uniformity and high depth of coverage, allowing the confident detection of [A] a SF3B1 exon 15 hotspot variant Lys700Glu with 4.8% allele frequency and [B] a TP53 exon 4 frameshift deletion (TP53 c.124del) with frequency 38.9%.

View Product

FISH probes

Chromosome map and microscope image for the FDA-cleared CytoCell P53 (TP53) Deletion FISH probe.

CytoCell P53 (TP53) Deletion

The P53 (TP53) Deletion FISH Probe Kit consists of a 161kb probe, labeled in Texas Red, covering the whole P53 (TP53) gene, extending 74kb telomeric to the gene and covering a region centromeric to the gene, to just beyond the marker D17S655; and a probe, labelled in FITC green, covering the chromosome 17 centromere (D17Z1) region.

View Product
Chromosome map and microscope image for the FDA-cleared CytoCell MLL (KMT2A) Breakapart FISH probe.

CytoCell MLL (KMT2A) Breakapart

The MLL (KMT2A) Breakapart FISH Probe Kit consists of an 87kb probe, labeled in Texas Red, covering a region telemetric to the MLL (KMT2A) gene including the marker SHGC-111513 and a FITC green probe covering a 170kb region centromeric to the MLL (KMT2A) gene spanning the CD3G and UBE4A genes.

View Product

Arrays

Schematic of the OGT SNP probe technology showing a hybridisation and signal match and mismatch.

CytoSure Cancer +SNP

OGT’s range of CytoSure® Cancer +SNP arrays combine long-oligo probes for superior copy number variant (CNV) detection alongside single nucleotide polymorphism (SNP) probes – which function using OGT proprietary technology – for accurate identification of loss-of-heterozygosity (LOH). The figure (above) shows a schematic of OGT’s unique SNP probe technology, allowing the use of any reference sample with no restriction digest.

View Product
Schematic showing how multiple arrays on a single slide can reduce costs and improve consistency.

CytoSure Custom Designed aCGH Arrays

Benefit from OGT’s extensive array design expertise to produce an array matching your precise specifications. These arrays are ideal if you want to know the precise coordinates of an aberration by analyzing specific areas of the genome at high resolution. The figure (above) shows how our custom arrays can be designed in a variety of formats depending on your desired level of focus, with 1, 2, 4, or 8 arrays available per slide to provide the most cost-effective solution for your research.

View Product
View all products

Featured resources

View more resources and support

Have a question or want to know more about our hematological cancer products?

Call +44 (0)1865 856800 Email contact@ogt.com Send us a message and we will get back to you